AAAAAA
Results:
1-23
|
Results: 23
Authors:
Gadamasetti, KG
Citation: Kg. Gadamasetti, Process chemistry in the pharmaceutical industry: An overview, PROCESS CHEMISTRY IN THE PHARMACEUTICAL INDUSTRY, 1999, pp. 3-17
Authors:
Cimarusti, CM
Citation: Cm. Cimarusti, Process research and development strategy for accelerated projects, PROCESS CHEMISTRY IN THE PHARMACEUTICAL INDUSTRY, 1999, pp. 21-34
Authors:
Mueller, RH
Citation: Rh. Mueller, Practical synthesis of ifetroban sodium, PROCESS CHEMISTRY IN THE PHARMACEUTICAL INDUSTRY, 1999, pp. 37-55
Authors:
Lantos, I
Matsuoka, R
Citation: I. Lantos et R. Matsuoka, Synthesis of 5-lipoxygenase inhibitors, PROCESS CHEMISTRY IN THE PHARMACEUTICAL INDUSTRY, 1999, pp. 57-71
Authors:
Okabe, M
Citation: M. Okabe, Chemistry of vitamin D: A challenging field for process research, PROCESS CHEMISTRY IN THE PHARMACEUTICAL INDUSTRY, 1999, pp. 73-89
Authors:
Federsel, HJ
Jakupovic, E
Citation: Hj. Federsel et E. Jakupovic, Highly optimized and concise large scale synthesis of a purine bronchodilator, PROCESS CHEMISTRY IN THE PHARMACEUTICAL INDUSTRY, 1999, pp. 91-106
Authors:
Farina, V
Grozinger, K
Muller-Botticher, H
Roth, GP
Citation: V. Farina et al., Ontazolast: The evolution of a process, PROCESS CHEMISTRY IN THE PHARMACEUTICAL INDUSTRY, 1999, pp. 107-124
Authors:
Walker, D
Citation: D. Walker, Dilevalol hydrochloride: Development of a commercial process, PROCESS CHEMISTRY IN THE PHARMACEUTICAL INDUSTRY, 1999, pp. 125-151
Authors:
Martinelli, MJ
Varie, DL
Citation: Mj. Martinelli et Dl. Varie, Design and development of practical syntheses of LY228729, a potent 5HT(1a) receptor agonist, PROCESS CHEMISTRY IN THE PHARMACEUTICAL INDUSTRY, 1999, pp. 153-172
Authors:
Giannousis, P
Carlson, J
Leimer, M
Citation: P. Giannousis et al., Process research and development of CGS 19755, an NMDA antagonist, PROCESS CHEMISTRY IN THE PHARMACEUTICAL INDUSTRY, 1999, pp. 173-188
Authors:
Blaser, HU
Gamboni, R
Pugin, B
Rihs, G
Sedelmeier, G
Schaub, B
Schmidt, E
Schmitz, B
Spindler, F
Wetter, H
Citation: Hu. Blaser et al., Route evaluation for the production of (R)-Levoprotiline, PROCESS CHEMISTRY IN THE PHARMACEUTICAL INDUSTRY, 1999, pp. 189-199
Authors:
Confalone, PN
Waltermire, RE
Citation: Pn. Confalone et Re. Waltermire, The process research and development of DuPont Merck's cyclic urea diols, a new class of HIV protease inhibitors, PROCESS CHEMISTRY IN THE PHARMACEUTICAL INDUSTRY, 1999, pp. 201-219
Authors:
Thiruvengadam, TK
Sudhakar, AR
Wu, GZ
Citation: Tk. Thiruvengadam et al., Practical enantio- and diastereo-selective processes for azetidinones, PROCESS CHEMISTRY IN THE PHARMACEUTICAL INDUSTRY, 1999, pp. 221-242
Authors:
McFarlane, IM
Newton, CG
Pitchen, P
Citation: Im. Mcfarlane et al., Synthesis of the common lactone moiety of HMG-CoA reductase inhibitors, PROCESS CHEMISTRY IN THE PHARMACEUTICAL INDUSTRY, 1999, pp. 243-259
Authors:
Anderson, BA
Hansen, MM
Vicenzi, JT
Zmijewski, MJ
Citation: Ba. Anderson et al., Chemistry, biocatalysis and engineering: An interdisciplinary approach to the manufacture of the benzodiazepine drug candidate LY300164, PROCESS CHEMISTRY IN THE PHARMACEUTICAL INDUSTRY, 1999, pp. 263-282
Authors:
Halpern, ME
Citation: Me. Halpern, Benefits and challenges of applying phase-transfer catalysis technology inthe pharmaceutical industry, PROCESS CHEMISTRY IN THE PHARMACEUTICAL INDUSTRY, 1999, pp. 283-298
Authors:
Partridge, JJ
Bray, BL
Citation: Jj. Partridge et Bl. Bray, Enantioselective synthesis: The optimum process, PROCESS CHEMISTRY IN THE PHARMACEUTICAL INDUSTRY, 1999, pp. 301-325
Authors:
Ayers, TA
RajanBabu, TV
Citation: Ta. Ayers et Tv. Rajanbabu, Practical catalysts for asymmetric synthesis: Ligands from natural sugars for Rh-catalyzed asymmetric synthesis of D- and L- amino acids, PROCESS CHEMISTRY IN THE PHARMACEUTICAL INDUSTRY, 1999, pp. 327-345
Authors:
Senanayake, CH
Jacobsen, EN
Citation: Ch. Senanayake et En. Jacobsen, Chiral (Salen)Mn(III) complexes in asymmetric epoxidations: Practical synthesis of cis-aminoindanol and tts applications to enantiopure drug synthesis, PROCESS CHEMISTRY IN THE PHARMACEUTICAL INDUSTRY, 1999, pp. 347-368
Authors:
Thompson, MD
Authelin, JR
Citation: Md. Thompson et Jr. Authelin, Chemical development of the drug substance solid form, PROCESS CHEMISTRY IN THE PHARMACEUTICAL INDUSTRY, 1999, pp. 371-388
Authors:
Hoffmann, W
Citation: W. Hoffmann, The basic principles of thermal process safety: Towards a better communication between safety experts and process chemists, PROCESS CHEMISTRY IN THE PHARMACEUTICAL INDUSTRY, 1999, pp. 389-408
Authors:
Pilipauskas, DR
Citation: Dr. Pilipauskas, Using factorial experiments in the development of process chemistry, PROCESS CHEMISTRY IN THE PHARMACEUTICAL INDUSTRY, 1999, pp. 411-428
Authors:
Owen, MR
Dewitt, SH
Citation: Mr. Owen et Sh. Dewitt, Laboratory automation in chemical development, PROCESS CHEMISTRY IN THE PHARMACEUTICAL INDUSTRY, 1999, pp. 429-455
Risultati:
1-23
|